XRP Adoption Expands to 6,000 US Pharmacies
Wellgistics Health incorporates XRP into its payment system across 6,000 US pharmacies, backed by a $50 million equity line from LDA Capital.
- Wellgistics Health launches XRP payments in pharmacies.
- Enhances speed, liquidity, and transparency in healthcare.
- XRP serves as payment and treasury asset.
The implementation highlights growing institutional interest in cryptocurrency, providing faster and cost-effective transactions. It marks a significant real-world application of blockchain technology in the healthcare sector.
Wellgistics Health Initiative
The initiative by Wellgistics Health, supported by a $50 million line of credit from LDA Capital, aims to transform healthcare payments with XRP’s integration. Wellgistics will use XRP to enhance payment speed and liquidity for 6,000 US pharmacies.
Brian Norton, CEO of Wellgistics Health, emphasizes the integration of blockchain technology to improve payment systems. The decision positions Wellgistics Health as a pioneering entity in healthcare, optimizing financial operations with XRP as a core asset.
“Our blockchain-enabled payment system and ledger is just the next logical step in healthcare evolution, allowing us to hardwire speed, liquidity, and transparency into a system that’s long been starved of all three.” — Brian Norton, CEO of Wellgistics Health
Implications for the Healthcare Industry
The payment transformation is expected to deliver real-time settlement, boosting efficiency in transactions between pharmacies, suppliers, and manufacturers. This move reflects growing interest in incorporating cryptocurrencies in traditional sectors.
XRP’s cost-effective framework, with less than $0.0002 per transaction, provides a stark contrast to traditional wire fees. Its integration proves advantageous for liquidity and financial control within pharmacy networks.
The broader implications could lead to increased adoption of XRP and similar technologies within the healthcare industry. While concerns regarding regulatory approval exist, the strategy could offer essential cost benefits and propel technological advances.
This initiative demonstrates how blockchain, through XRP, may continue influencing financial systems and operational efficiency. It highlights a potential shift in pharmaceutical distribution towards more scalable and agile financial frameworks.
More From Crypto News
Tether Signs Kazakhstan Central Bank MoU for Tenge Stablecoin
Tether has signed a memorandum of understanding with the National Bank of Kazakhstan to explore developing a stablecoin pegged to the Kazakhstani tenge, accordi...
XRP Narrow Range: Analyst Eyes Potential Move Toward $2
ChartNerd describes the current structure as neutral. A breakout would require a resistance break, a retest that holds as support, and a push through the local...
Hyperliquid Faces Singapore Regulatory Questions Despite Local HQ
Having a registered office in Singapore places Hyperliquid squarely within the oversight reach of the Monetary Authority of Singapore (MAS), the country’s centr...
US Spot XRP ETFs Hold $1.7B as Weekly Inflows Hit $4M
The $1. 7 billion aggregate represents cumulative assets under management across US-listed spot XRP ETFs as of Monday’s close, not single-day activity.
Ethereum Falls Nearly 6% as $1.35B Longs Face Liquidation
Ethereum slid nearly 6% on October 7, 2026, dropping to around $2,570 and leaving approximately $1. 35 billion in leveraged long positions at risk of forced liq...
Bank of Russia Registers Official Crypto Market Operators
By registering operators directly, the Bank of Russia positions itself as the supervisory authority over who may legally conduct crypto-market activity under Ru...
